Career history of Marie Kosco-Vilbois
Former positions of Marie Kosco-Vilbois
| Companies | Position | Start | End |
|---|---|---|---|
| AC IMMUNE SA | Chief Tech/Sci/R&D Officer | 02/01/2019 | 31/12/2023 |
| NOVIMMUNE SA | Chief Tech/Sci/R&D Officer | 31/12/2001 | 08/01/2019 |
| Serono Pharmaceutical Research Institute | Corporate Officer/Principal | 31/12/2000 | 31/12/2000 |
| Basel Institute for Immunology | Corporate Officer/Principal | - | - |
| Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | - | - |
Training of Marie Kosco-Vilbois
| Rutgers State University of New Jersey | Undergraduate Degree |
| Medical College of Virginia | Doctorate Degree |
Statistics
International
| Switzerland | 6 |
| France | 2 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Private companies | 3 |
|---|---|
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
| Serono Pharmaceutical Research Institute | |
| Glaxo-Welcomes' Research Institute |
- Stock Market
- Insiders
- Marie Kosco-Vilbois
- Experience
